Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06984523 · ClinicalTrials.gov registry record · NA
Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis
A NA study, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06984523 is a NA study that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 20 participants.
The verdict
NCT06984523, a NA study, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm the safety and efficacy of linac based Volumetric Modulated Arc Therapy (VMAT) for craniospinal irradiation (CSI) in solid tumor cancer patients with leptomeningeal metastasis. The primary aim is to determine if linac based VMAT CSI for leptomeningeal metastasis improves central nervous system (CNS) progression free survival (PFS) compared to the historical standard control CNS PFS in patients treated with Involved Field Radiation Therapy (IFRT).
Interventions
- RADIATION Varian Eclipse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2028-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06984523
The ClinicalTrials.gov registry entry for NCT06984523 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Varian Eclipse is the first listed.
NCT06984523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06984523 about?
NCT06984523 is a clinical study titled "Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis". The purpose of this study is to confirm the safety and efficacy of linac based Volumetric Modulated Arc Therapy (VMAT) for craniospinal irradiation (CSI) in solid tumor cancer patients with leptomeningeal metastasis. The primary aim is to determine if linac based VMAT CSI for leptomeningeal metastas...
What is the current status of trial NCT06984523?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-14. Estimated completion is 2028-05-12.
What interventions are being tested in trial NCT06984523?
The interventions under investigation include: Varian Eclipse (RADIATION).
Who is sponsoring clinical trial NCT06984523?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.